FcγRIIB expression was significantly correlated with the enrichment score of the mesenchymal signature (R = 0.7919, p < 2.2e-16) (Fig 3A) and moderately with IGFBP2 expression (R = 0.22, p < 0.012) in gliomas. Here, FCGR2B is linked to central nervous system cancer.